{"id":"W4391815864","doi":"10.1186/s13023-024-03059-3","title":"EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders","year":2024,"lang":"en","type":"review","venue":"Orphanet Journal of Rare Diseases","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Novartis Pharma; Prinses Beatrix Spierfonds; Ataxia UK; Argenx; Alexion Pharmaceuticals; E-Rare; Cytokinetics; Amicus Therapeutics; CSL Behring; Medical Research Council; AveXis; Biogen; European Commission; Sanofi; Third Health Programme; Ipsen; Alnylam Pharmaceuticals; Italfarmaco; Wellcome Trust; Ministero della Salute; Pfizer","keywords":"Disease registry; Interoperability; Patient registry; Medicine; Neuromuscular disease; Health information exchange; European commission; Business; Disease; Computer science; Health care; Family medicine; Pathology; World Wide Web; Pediatrics; Political science; European union","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.02496373,0.0004381058,0.0008397895,0.004164872,0.0006373874,0.004158794,0.003039128,0.002113017,0.004106925],"category_scores_gemma":[0.02146028,0.0002798609,0.001138614,0.004316844,0.001645918,0.005773583,0.005874309,0.001809184,0.001712764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00250652,"about_ca_system_score_gemma":0.01160214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002281243,"about_ca_topic_score_gemma":0.001203731,"domain_scores_codex":[0.9912336,0.00436698,0.001345586,0.0008093495,0.001824929,0.0004195356],"domain_scores_gemma":[0.9870235,0.005889726,0.001476892,0.002394217,0.002123259,0.001092466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002027951,0.0001058985,0.003121965,0.006507804,0.0002489067,0.0004544096,0.0007423429,0.002194225,0.0005916721,0.2698266,0.07987129,0.6361322],"study_design_scores_gemma":[0.00006521872,0.00007239875,0.002018049,0.006379363,0.0001199713,0.001235044,0.0001940083,0.0006959045,0.0004883019,0.0211484,0.9675487,0.00003470134],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01275197,0.6158808,0.1997181,0.06736727,0.008388336,0.002036897,0.007095876,0.004767418,0.08199321],"genre_scores_gemma":[0.1866105,0.4475001,0.2992125,0.01877171,0.004567812,0.003890886,0.02235232,0.0008538131,0.01624038],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9969609,"threshold_uncertainty_score":0.1320224,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01660152034423282,"score_gpt":0.2963952726096451,"score_spread":0.2797937522654123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}